Probi

With its high brand recognition, Probi is the market leader in the category "dietary supplements with lactic acid bacteria" on the Swedish market. The products are mainly sold via pharmacies, both in physical stores and online. Probi is already present on the Norwegian and Icelandic markets.

The new sales and marketing organization that Probi AB established just under a year ago is working to create the right conditions for the brand to be able to expand further in the Nordic market and deliver strong growth in 2024. During the spring, Danish consumers will now also be offered Probi's products via Matas' e-commerce platform.

"We are very happy to enter the Danish market by starting a commercial collaboration with the well-known retail chain Matas" says Joakim Dahlgren Hagstedt, Sales Manager B2C, Probi AB.

At the same time, the focus is to strengthen Probi's brand strategy with a new brand identity and communication together with building a strong product portfolio to ensure that Probi has a relevant and attractive offer on the entire Nordic market. To implement this, a strategic collaboration has been started together with the strategy- and design agency Silver.

"Together with Silver, we want to take Probi to the next level in the entire Nordic market - both in terms of packaging design and communication expression. By further developing the brand, we will strengthen our category leadership and continue to grow by entering new markets" says Alexia Wilhelmsson, Marketing Manager B2C, Probi AB.

For further information, please contact:

Martina Pettersson, Global Marketing Director, Probi AB

Phone: +46 46 286 89 61, E-mail: martina.pettersson@probi.com
 

ABOUT PROBI

Probi^® is a global company focused exclusively on researching, manufacturing, and delivering probiotics for
supplements and functional food. We are experts at managing stable, live bacteria from R&D through every
stage of the manufacturing process and are dedicated to making the health-enhancing benefits of probiotics
available to people everywhere. Our health concepts, formulations, and formats are supported by robust clinical documentation. Since our founding in 1991 at Sweden's Lund University, Probi has expanded its operations to more than 40 markets. We hold more than 400 patents globally. Probi had sales of SEK 628 m in 2023. Probi's shares are listed on Nasdaq Stockholm, Mid-cap, and there were around 3,400 shareholders on December 31, 2023.